Clinical Trials on Esophageal Neoplasms in Chile

Total 583 results

Sanofi
Merck Sharp & Dohme LLC

Active, not recruiting

A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Gastrointestinal Cancer (Master Protocol) (Pegathor Gastrointestinal 203)

Hepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | Oesophageal Adenocarcinoma | Oesophageal Squamous Cell Carcinoma

Korea, Republic of, Belgium, Italy, United States, Chile, China, France, Netherlands, Spain
EndoStim Inc.

Completed

Feasibility Study for Evaluating the Effect of Electrical Stimulation on Lower Esophageal Sphincter Pressure and Esophageal Acid Exposure in Patients With Gastroesophageal Reflux Disease

Gastroesophageal Reflux Disease

Chile
Cirujanos la Serena

Completed

Pancreaticobiliary Reflux in Patients Without Cholelithiasis

Pancreaticobiliary Reflux

Chile
AstraZeneca

Completed

A Study of Nexium (Esomeprazole) 40 mg Once Daily in Subjects With Symptoms of Gastroesophageal Reflux Disease (GORD) After Treatment With a Full Dose of Proton Pump Inhibitor (PPI) (NEON)

Gastroesophageal Reflux Disease

Chile, Argentina, Venezuela, Colombia
Pontificia Universidad Catolica de Chile

Completed

Multimodal Assesment of Acute Cardiac Toxicity Induced by Thoracic Radiotherapy in Cancer Patients

Cancer | Breast Cancer | Esophageal Cancer | Lung Cancer | Cardiotoxicity | Radiotherapy; Complications

Chile
University of Chile
Comisión Nacional de Investigación Científica y Tecnológica

Unknown

Early Percutaneous Tracheostomy and Swallowing Dysfunction

Swallowing Disorder

Chile
Merck Sharp & Dohme LLC

Active, not recruiting

A Study of Combination Therapies With or Without Pembrolizumab (MK-3475) and/or Chemotherapy in Participants With Advanced Esophageal Cancer (MK-3475-06A)

Esophageal Squamous Cell Carcinoma (ESCC)

Japan, Italy, Brazil, Chile, France, Germany, Korea, Republic of, Norway, Singapore, Switzerland, Taiwan, Thailand, Turkey
Merck Sharp & Dohme LLC

Recruiting

A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)

Esophageal Squamous Cell Carcinoma

Japan, Korea, Republic of, Taiwan, China, Italy, Switzerland, Brazil, Germany, Singapore, Turkey, Thailand, Chile, Norway
University of Chile

Completed

Ultra Structure Of Peritoneum At Electronic Microscopy In Control Subjects And Patients With Gastric Cancer

Stomach Neoplasm

Chile
EndoStim Inc.

Unknown

Effect of Long-Term Electrical Stimulation on LES Pressure and Esophageal Acid Exposure in Patients With GERD

Gastroesophageal Reflux Disease

Chile, Colombia, India, Mexico, Netherlands, New Zealand, United Kingdom
Pontificia Universidad Catolica de Chile
Center of Excellence of Precision Medicine (CEMP); Advanced Center for Chronic... and other collaborators

Completed

Chilean Gastric Cancer Task Force (FORCE 1) (FORCE-1)

Biomarkers

Chile
Merck Sharp & Dohme LLC

Active, not recruiting

Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Who Are Receiving Chemotherapy and Radiation Therapy (MK-3475-975/KEYNOTE-975)

Esophageal Squamous Cell Carcinoma (ESCC) | Gastroesophageal Junction Carcinoma (GEJC) | Esophageal Adenocarcinoma (EAC)

China, Canada, United States, Argentina, Belgium, Brazil, Chile, Czechia, Denmark, Estonia, France, Germany, Guatemala, Hong Kong, Hungary, Italy, Japan, Korea, Republic of, Mexico, Peru, Philippines, Portugal, Romania, Russian Federation and more
Merck Sharp & Dohme LLC

Completed

First-line Esophageal Carcinoma Study With Pembrolizumab Plus Chemo vs. Chemo (MK-3475-590/KEYNOTE-590)

Esophageal Neoplasms

Taiwan, China, United States, Argentina, Australia, Brazil, Canada, Chile, Colombia, Costa Rica, Denmark, France, Germany, Guatemala, Hong Kong, Japan, Korea, Republic of, Malaysia, Peru, Romania, Russian Federation, South Africa, S... and more
Pontificia Universidad Catolica de Chile
Fondo Nacional de Desarrollo Científico y Tecnológico, Chile

Unknown

Resistance to Immunotherapy in Gastric Cancer (MERIT)

Metastatic Gastric Cancer

Chile
Merck Sharp & Dohme LLC
Eisai Inc.

Recruiting

Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Plus Chemotherapy in Participants With Metastatic Esophageal Carcinoma (MK-7902-014/E7080-G000-320/LEAP-014)

Metastatic Esophageal Squamous Cell Carcinoma

Argentina, Chile, United States, Canada, China, Costa Rica, Denmark, France, Guatemala, Hong Kong, Hungary, Italy, Japan, Korea, Republic of, Russian Federation, Spain, Taiwan, Turkey, United Kingdom, Romania, Ukraine, Singapore, Ma... and more
Pontificia Universidad Catolica de Chile
Comisión Nacional de Investigación Científica y Tecnológica

Recruiting

The Effect of a Patient Decision Aids for Breast Cancer Screening

Breast Cancer | Breast Tumor | Mammary Cancer | Mammary Tumor

Chile
Universidad de La Frontera

Completed

Resistance-type Exercise Training in Postmenopausal Women Survivors of Breast Cancer (MUSCLE-CLIM)

Resistance Training | Postmenopause | Breast Cancer Survivors

Chile
Pontificia Universidad Catolica de Chile
Centro de Salud Familiar El Roble

Unknown

Messages For Your Health: A Cancer Screening Prevention Study

Cervical Cancer

Chile
Servicio de Salud Metropolitano Sur Oriente

Recruiting

No Operation After Short Course Radiotherapy Followed By Consolidation Chemotherapy In Locally Advanced Rectal Cancer (NOAHS-ARC)

Rectal Cancer

Chile
Grupo Oncologico Cooperativo Chileno de Investigation

Completed

Observational Study of Perioperative Chemotherapy in Gastric Cancer (PRECISO)

Gastric Cancer

Chile
Pontificia Universidad Catolica de Chile

Unknown

Impact of Adjuvant FOLFOX on Quality of Life and Sensory Neurotoxicity in Patients With Advanced Gastric Cancer

Stomach Neoplasms

Chile
National Cancer Institute (NCI)

Completed

Chile Biliary Longitudinal Study

Gallbladder Cancer | Nutritional and Metabolic Diseases

Chile
Hospital Dr Sotero del Rio

Unknown

Severe Complications After Gastrectomy for Esophagogastric Junction and Gastric Cancer

Gastric Cancer | Esophagogastric Junction Disorder

Chile
Pontificia Universidad Catolica de Chile

Recruiting

Randomized Pilot Study of Radiosurgery for the Treatment of Non-metastatic Prostate Cancer

Quality of Life | Prostatic Neoplasms | Radiosurgery

Chile
University of Chile

Not yet recruiting

Real-time Ultrasound Guidance for Thoracic Epidural Blocks

Analgesia | Rib Fractures | Thoracic Tumors | Abdomen Tumors

Chile
University of Chile

Completed

Immunization With Autologous Dendritic Cells and Tumor Lysates in Melanoma Patients

Stage III Malignant Melanoma of Skin AJCC V6 | Stage IV Malignant Melanoma of Skin

Chile
Pontificia Universidad Catolica de Chile

Unknown

Effect of Dexmedetomidine on Plasmatic Cortisol Response in Transsphenoidal Surgery

Pituitary Neoplasms

Chile
Universidade Federal de Sao Carlos

Suspended

Short and Long Term Effects of a Physical Therapy Program After Breast Cancer Surgery

Breast Cancer

Chile
Universidad de La Frontera

Not yet recruiting

Manual Therapy for Oral Health on Head and Neck Cancer Survivors (MaTeO)

Head and Neck Cancer | Trismus | Dysfunction

Chile
Cirujanos la Serena

Completed

Current Management of Gastrointestinal Stromal Tumors (GIST) in the Region of Coquimbo

Gastrointestinal Stromal Tumors

Chile
Universidad de La Frontera

Not yet recruiting

Prehabilitation With Resistance-exercise Training for Breast Cancer Neoadjuvant Therapy (PRE-RET)

Breast Cancer | Resistance Training | Postmenopause | Prehabilitation

Chile
St. Jude Children's Research Hospital
National Eye Institute (NEI)

Completed

Molecular Analysis of Retinoblastoma

Retinoblastoma

Chile, Honduras
Pontificia Universidad Catolica de Chile

Completed

Premedication With Simethicone or Simethicone Plus N-acetylcysteine in Improving Visibility During Upper Endoscopy (PRUE)

Stomach Neoplasms

Chile
Instituto de Nutrición y Tecnología de los Alimentos
Pontificia Universidad Catolica de Chile; Servicio de Salud Metropolitano Sur...

Active, not recruiting

Chilean Maternal & Infant Cohort Study II (CHiMINCs-II) (CHiMINCs-II)

Nutritional Status | Body Composition | Breast Density | Mental Health Issue

Chile
Universidad del Desarrollo
Agencia Nacional de Investigación y Desarrollo; Clínica Dávila

Not yet recruiting

Photobiomodulation for Oral Mucositis and Functional Impairments During Hematopoietic Stem Cell Transplantation (POMFITT)

Hematologic Cancer

Chile
Gerardo F Fasce Pineda, MD

Active, not recruiting

Impact on General Functionality of an Immediate Prosthetic Functionalization Protocol in People Over 70 Years of Age With Deficient Removable Prostheses

Elderly | Functional Status | Dental Restoration | Removable Dental Prosthesis

Chile
Jazz Pharmaceuticals
BeiGene, Ltd.

Recruiting

A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers (HERIZON-GEA-01)

Gastroesophageal Adenocarcinoma | Esophageal Adenocarcinoma | Gastric Neoplasms

Korea, Republic of, Belgium, Japan, China, Netherlands, Spain, Germany, United Kingdom, Malaysia, Portugal, France, Italy, Australia, Taiwan, Turkey, Thailand, Argentina, Mexico, Ireland, Estonia, Serbia, Romania, Canada, Poland, Brazil, ... and more
Pontificia Universidad Catolica de Chile

Recruiting

Virtual Exercise on Elderly Breast Cancer Survivors

Breast Cancer

Chile
Pontificia Universidad Catolica de Chile
Hoffmann-La Roche; Ministerio de Salud de Chile; Red Salud UC

Unknown

Detection of Methylated Reprimo in Plasma for Asymptomatic Gastric Cancer (DEMRAC)

Early Gastric Cancer

Chile
Merck Sharp & Dohme LLC

Active, not recruiting

Pembrolizumab/Placebo Plus Trastuzumab Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-811/KEYNOTE-811)

Gastric Neoplasms | Gastroesophageal Junction Adenocarcinoma

United States, Australia, Brazil, Chile, China, France, Germany, Guatemala, Ireland, Israel, Italy, Japan, Korea, Republic of, New Zealand, Poland, Russian Federation, Spain, Turkey, Ukraine, United Kingdom
National Cancer Institute (NCI)
Pontificia Universidad Catolica de Chile

Completed

Initial Study of Gallbladder Cancer in Chile

Gallbaldder Cancer

Chile
Ingalfarma SpA

Completed

Study of Dentoxol® Mouthrinse for Oral Mucositis

Oral Mucositis

Chile
Clinica las Condes, Chile
Solta Medical; Corporacion de ayuda al niño quemado (COANIQUEM)

Unknown

Fractional Photothermolysis for the Treatment of Burn Scars

Scar

Chile
Hospital San Juan de Dios, Santiago

Completed

Protective Role of N-acetylcisteine From Cisplatin-induced Ototoxicity in Patients With Head and Neck Cancer

Cisplatin Adverse Reaction | Hearing Loss Ototoxic

Chile
Pontificia Universidad Catolica de Chile
European Union; Agencia Nacional de Investigación y Desarrollo

Completed

Endoscopic Surveillance on a High-risk Population for Gastric Cancer in Latin America: The ECHOS Cohort Study. (ECHOS)

Gastric Cancer | Helicobacter Pylori Infection | Atrophic Gastritis | Dysplasia Stomach

Chile
Hernán González

Completed

Validation of a Multi-Genetic Test for the Diagnosis of Indeterminate Thyroid Nodules (CT-DS)

Indeterminate Thyroid Cytology

Chile
AstraZeneca

Completed

Evaluation in Real World of Molecular Testing and Treatment Patterns for EGFR Mutation in Lung Cancer Patients (PANORAMRETRO)

Carcinoma, Non-Small-Cell Lung

Argentina, Colombia, Uruguay, Chile
Universidad de Valparaiso
Comisión Nacional de Investigación Científica y Tecnológica

Unknown

Near to Infrared (NIR) Light Neuroprotection in Glaucomatous Optic Neuropathy

Open Angle Glaucoma

Chile
Pontificia Universidad Catolica de Chile
Universidad de Granada; Hospital Dr Sotero del Rio; National Fund for Research...

Recruiting

Supervised Resistance TRaining amONG Women at Risk of Breast Cancer Related Lymphedema (STRONG-B)

Breast Cancer | Physical Activity | Lymphedema of Upper Arm

Chile
Amgen

Recruiting

Bemarituzumab Plus Chemotherapy and Nivolumab Versus Chemotherapy and Nivolumab for FGFR2b Overexpressed Untreated Advanced Gastric and Gastroesophageal Junction Cancer (FORTITUDE-102)

Gastric Cancer | Gastroesophageal Junction Adenocarcinoma

Korea, Republic of, United States, Israel, Italy, Spain, Switzerland, Canada, Australia, Germany, United Kingdom, Austria, France, Japan, Taiwan, China, Belgium, Poland, Thailand, Czechia, Singapore, Hungary, Argentina, Brazil, Romania, Portuga... and more

Clinical Trials on Esophageal Neoplasms in Chile

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Croatia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations